At OrbusNeich, we offer careers that are challenging, rewarding and energizing as we strive to push the boundaries of medicine to become the most innovative coronary stent company in the world.
Established in 2005 and headquartered in Hong Kong, we conduct business in over 60 countries across six continents to deliver proven cardiology solutions. With more than 500 employees, we play an important role in improving the lives of people with heart disease.
We are dedicated to the development and delivery of cutting edge research and novel technology. Our focus is on providing healthcare professionals with innovative solutions for the treatment of vascular disease to improve the lives of patients around the world.
For more information and news, visit http://www.orbusneich.com/ or follow us on Twitter @OrbusNeich
Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 18, 2018 | Cardiovascular Systems inks partnerships with OrbusNeich, Integer | Cardiovascular Systems (Nasdaq: CSII) announced today that it is expanding its product portfolio through new partnerships with OrbusNeich and Integer. The OrbusNeich partnership makes St. Paul, Minn.–based CSI the exclusive U.S. distributor... |
| Sep 17, 2013 | BSX pays out to OrbusNeich to settle stent lawsuit woes | Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Mar 14, 2013 | OrbusNeich takes Boston Scientific patent row to Ireland | OrbusNeich continued its global row against medtech titan Boston Scientific (NYSE:BSX) even further, filing a patent infringement lawsuit in Ireland to join ones pending in Germany and the Netherlands. Much like the prior lawsuits, the new ... |
| OrbusNeich Medical | “Forging new paths in the treatment of vascular diseases with our range of innovative devices including balloons, stents and speciality catheters” | |
| BSX pays out to OrbusNeich to settle stent lawsuit woes | Boston Scientific (BSX) has agreed to make an undisclosed, one-time payment to OrbusNeich to settle all stent-based litigation. This includes settling lawsuits in the United States, the Netherlands, Ireland, Germany and the UK. OrbusNeich i... |
Reviews 0
FAQ about OrbusNeich Medical Company Ltd.
When was OrbusNeich Medical Company Ltd. founded?
OrbusNeich Medical Company Ltd. was founded in 2005.
How much funding has OrbusNeich Medical Company Ltd. raised?
OrbusNeich Medical Company Ltd. has raised $200M in total across 1 funding round.
What has the press written about OrbusNeich Medical Company Ltd.?
Parsers VC has collected 6 articles mentioning OrbusNeich Medical Company Ltd., among them “Cardiovascular Systems inks partnerships with OrbusNeich, Integer” (Jan 18, 2018) and “BSX pays out to OrbusNeich to settle stent lawsuit woes” (Sep 17, 2013).
Is OrbusNeich Medical Company Ltd. still active?
Yes, OrbusNeich Medical Company Ltd. is active; its latest activity on Parsers VC dates from May 20, 2021.